Integral Diagnostics Ltd · ASX:IDX
Integral Diagnostics — Shareholder Meeting (November 2018)
12 slides from Integral Diagnostics's shareholder meeting presentation, Nov 16, 2018
Slide 1: 2018 AGM
For personal use only 2018 AGM Dr. Ian Kadish (MD & CEO) 16 November 2018 0
Slide 2: Integral Diagnostics is a leading diagnostic imaging business
Integral Diagnostics (IDX) is a leading Diagnostic Imaging business in Victoria, Queensland, Western Australia and as of 2/7/18 also in New Zealand For personal use only A leading provider in each geography we serve Comprehensive offerings (X-Ray, CT, Ultrasound, MRI, Nuclear Medicine and PET)
Slide 3: Operating in four key markets
Operating in four key markets Total IDX For personal use only Geographic Victoria Queensland Western Australia New Zealand Market Ballarat, Geelong, Gold Coast, Warrnambool South West Core markets Toowoomba and Auckland and outer Western Australia Mackay Western areas of Melbourne Sites (includes 27
Slide 4: Our Culture: Good Medicine is Good Business
Our Culture: Good Medicine is Good Business At IDX we always put the patient first. By putting our patients first we also put our shareholders first For personal use only We provide a comprehensive diagnostic imaging service and concentrate on geographies where we build a leading position Radiol
Slide 5: Growing across key financial metrics
Growing across key financial metrics Revenue ($m) Operating EBITDA ($m) For personal use only 189.4 38.1 179.7 34.9 167.8 33.5 FY16 FY17 FY18 FY16 FY17 FY18 Operating NPAT ($m) Fully Franked Dividends 18.2 4¢ 16.6 Final Dividend 3¢ Interim Dividend 15.1 4¢ 4¢ 4¢ FY16 FY17 FY18 FY16 FY17 FY18 4
Slide 6: Share price performance
Share price performance Share price performance 2.0 Index For personal use only Reaffirmed FY18 Integral Diagnostics guidance. FY18 Results Acquisition of GMI release S&P/ASX Small Industrials 1.8 HY18 results release 69% 1.6 Anne Lockwood CAJ replacement appointed as CFO bidder statement IDX comple
Slide 7: Medicare growth in the states where we operate
Medicare growth in the states where we operate For personal use only Medicare revenue growth on long-term average around 7% Prostate MRI included on MBS from 1/7/18 GP referred knee MRI removed from MBS on 1/11/18 Medicare announced 10 new MRI licenses in October Pindara Hospital MRI upgra
Slide 8: Successfully integrating NZ Clinics
Successfully integrating NZ Clinics Performance of the NZ business post acquisition is on track For personal use only Exceptional team, across the board Revenue and earnings on plan Operational integration well underway GM appointed and commenced Radiologists on IDX Clinical Leadership Com
Slide 9: Industry Leadership
Industry Leadership IDX plays an active role in ensuring that Australian and New Zealand Diagnostic Imaging services retain their pre-eminent position and reputation for high quality of For personal use only care and services, training and research. Sponsor of the graduation ceremony for the Royal
Slide 10: Corporate Social Responsibility
Corporate Social Responsibility IDX actively participates and drives social programs that assist patients in need to access vital diagnostic imaging services For personal use only Radiology Across Borders Strategic partnership with Radiology Across Borders (RAB) to provide radiology development and
Slide 11: Key Priorities for FY19 and Operating Update
Key Priorities for FY19 and Operating Update In FY19 our priorities are to: Drive organic growth and further efficiency gains For personal use only Use digital technology to improve the patient and referrer experience Open a Prostate Imaging Centre of Excellence with the Australia Prostate C
Slide 12: Disclaimer
Disclaimer Some of the information contained in this presentation contains “forward-looking statements” which may not directly or exclusively relate to historical facts. These forward-looking statements reflect Integral Diagnostics Limited (IDX) current intentions, plans, expectations, assumptions a
Integral Diagnostics — Shareholder Meeting (November 2018) on 6ix